blood clot formation
DESCRIPTION
Blood Clot Formation. ATLAS ACS 2—TIMI 51 Design. ATLAS-2 Patients With Biomarker Elevation, n = 12,626. ATLAS-2 Patients With Biomarker Elevation, n = 12,626. APPRAISE-2. ATLAS-ACS TIMI 46. Newer Antiplatelet Agents. WOEST Efficacy End Points. WOEST Bleeding Events. - PowerPoint PPT PresentationTRANSCRIPT
Blood Clot Formation
ATLAS ACS 2—TIMI 51Design
ATLAS-2Patients With Biomarker Elevation, n =
12,626
ATLAS-2Patients With Biomarker Elevation, n =
12,626
APPRAISE-2
ATLAS-ACS TIMI 46
Newer Antiplatelet Agents
WOESTEfficacy End Points
WOESTBleeding Events